SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-19-008828
Filing Date
2019-06-07
Accepted
2019-06-06 17:32:16
Documents
7
Period of Report
2019-06-06

Document Format Files

Seq Description Document Type Size
1 formpre14a.htm PRE 14A 499102
2 formpre14a_001.jpg GRAPHIC 3964
3 formpre14a_002.jpg GRAPHIC 2610
4 image_001.jpg GRAPHIC 2610
5 proxy_001.jpg GRAPHIC 301244
6 proxy_002.jpg GRAPHIC 382196
7 proxy_003.jpg GRAPHIC 214461
  Complete submission text file 0001493152-19-008828.txt   1749797
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37648 | Film No.: 19883527
SIC: 2835 In Vitro & In Vivo Diagnostic Substances